Investment Date
December 2021
Subsector
PharmaBio, MedTech
Website
biocare.net/
Status
Current
Corporate HQ
California, US

Biocare Medical is a leading developer of oncology focused immunohistochemistry (IHC) and in situ hybridisation (ISH) reagents for diagnosis and hromosomal profiling alongside an array of diagnostics instruments.

The Biocare portfolio of high-quality antibodies provides increased confidence for laboratory processes and critical diagnostics for patient therapies. The company’s core customers focus on clinical laboratories, bio-pharmaceutical companies and CRO’s.

GHO value creation

Enablement & Alignment

  • Opportunity to create a global industry leader in IHC and ISH, servicing clinical labs and innovators in Pharma and Biotech

Capability & Capacity

  • Enhanced investment and continued focus on product research and development as the business continues to target attractive adjacencies
  • Development of further instrument lines driving significant market evolution to target underserved markets

Building Strategic Footprints

  • Execution of organic and inorganic geographic expansion, in support of increasing global customer demand

Better, faster + more accessible healthcare

GHO Capital invests in Biocare Medical, a global leader in oncology-focused diagnostic reagents and instrumentation

Subscribe to our email alerts

Email updates